Pharyngeal electrical stimulation in patients with neurogenic dysphagia not responding to standard therapy (PES-NOREST): double blind, randomized clinical trial of efficacy.
- Conditions
- R13.0
- Registration Number
- DRKS00016845
- Lead Sponsor
- Schön Klinik Bad Aibling
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 82
ischemic or hemorrhagic stroke
-one-time monohemispheric lesion
-positive standardized aspiration screening (modified Evan´s Blue Dye Test (Belafsky et al., 2003); TOR-BSST (Martino et al. 2009))
-Bogenhausener Dysphagie Score 2 (oral diet) =5
-Functional oral intake scale (Crary et al. 2005) FOIS =3
-need for feeding tube or intravenous Infusion
-Need for feeding tube + PAS =6 persist 4 weeks post onset
-Patient received a minimum of 8 units traditional dysphagia therapy
-endoscopically proven aspiration (Penetration-Aspiration Scale PAS =6) for at least one consistency
-inpatient at Schön Klinik Bad Aibling
-no informed consent
-pre-existing dysphagia
-cardiac pacemaker
-implanted defibrillator
-continuous need for oxygen
-pre-existing neurologic or morphologic-anatomic lesions
-brainstem or cerebellar lesion
-2nd motor neuron n. recurrens lesion
-insufficient refelctory cough
-oro-pharyngo-esophageal tumors
-severe non-substitutional coagulation deficits
-partial respiratory insufficiency (Sa02 < 90%)
-bradycardia < 50/min
-pregnancy
-simultaneous inclusion in another clinical trial
-delay between FEES at baseline and study inclusion < 7 days
-metallic or electronic cerebral implants
-skin lesions in the region of stimulation, mainly eczema, psoriasis, dermatitis
-epilepsy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of the Penetration-Aspiration scale (PAS; Rosenbek et al. 1996) for the consistencies saliva, water and puree determinded by flexible endoscopic Evaluation of swallowing (FEES) at baseline and at one week post stimulation.
- Secondary Outcome Measures
Name Time Method -Yale Residue Scale (Neubauer et al. 2015)<br>-Bogenhausener Dysphagie-scales (BODS1 und BODS2) (Bartolome et al. 2018)<br>-Functional Oral Intake Scale (FOIS) (Crary et al. 2005)<br>-Dysphagia Severity Rating Scale (DSRS) (Jayasekeran et al. 2010)<br>-swallowing frequency during 5 minutes (tactile measurement)<br>-National Institute of Health Stroke Scale (NIHSS)<br>-Barthel Index<br>-Box-Block-Test<br>-Test of Attentional Performance (TAP), Untertest Alertness<br>-Test of Attentional Performance (TAP), Untertest Go/ NoGo<br><br>Timeline for measurements: baseline, 1 week post stimulation, 3 weeks post stimulation (BODS1, BODS 2, DSRS, FOIS, swallowing frequency, Barthel Index)